Advertisement

Vulvar Disease pp 371-378 | Cite as

Vulvar Intraepithelial Neoplasia

  • Fabrizio Bogliatto
Chapter

Abstract

No standard screening programs are manageable to detect vulvar carcinoma or its precursor lesions, and therefore gynecologists, dermatologists, and other healthcare providers in the field of vulvar disorders should be aware of the clinical features, behavior, and management of the premalignant vulvar lesions, squamous vulvar intraepithelial neoplasia (VIN). During the years, studies on vulvar cancer demonstrated there are two types of disease: one HPV related and one occurring in the absence of HPV, but usually related to dermatoses such as lichen sclerosus or lichen planus. In 2015, a new classification for squamous VIN was introduced by the International Society for the Study of Vulvar Disease (ISSVD), following the LAST (Lower Anogenital Squamous Terminology) project. This review describes the relevant aspects of squamous VIN, its epidemiological characteristics, diagnosis, management, new treatment options, and malignant potential.

References

  1. 1.
    Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107:1018–22.CrossRefGoogle Scholar
  2. 2.
    Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol. 2005;106:1319–26.CrossRefGoogle Scholar
  3. 3.
    van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol. 2005;97:645–51.CrossRefGoogle Scholar
  4. 4.
    Watson M, Saraiya M, Wu X. Update of HPV-associated female genital cancers in the United States, 1999–2004. J Womens Health. 2009;18(11):1731–8.CrossRefGoogle Scholar
  5. 5.
    Smith JS, Backes DM, Hoot BE, et al. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol. 2009;113(4):917–24.CrossRefGoogle Scholar
  6. 6.
    Bowen JT. Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. J Cutan Dis. 1912;30:241–55.Google Scholar
  7. 7.
    Hudelo ML, Cailliau O. Dyskeratose erythroplasiforme de la muquese vulvaire. Bull Soc Fr Dermatol Syphiligr. 1922;29:139–42.Google Scholar
  8. 8.
    van Dyck Knight R. Bowen’s disease of the vulva. Am J Obstet Gynecol. 1943;46:514–24.CrossRefGoogle Scholar
  9. 9.
    Kaufman R, Gardner H. Intraepithelial carcinoma of the vulva. Clin Obstet Gynecol. 1965;8:1035–50.CrossRefGoogle Scholar
  10. 10.
    Friedrich EG Jr, Wilkinson EJ, Fu YS. Carcinoma in situ of the vulva: a continuing challenge. Am J Obstet Gynecol. 1980;136:830–43.CrossRefGoogle Scholar
  11. 11.
    ISSVD. New nomenclature for vulvar disease. Obstet Gynecol. 1976;47:122–4.Google Scholar
  12. 12.
    Darragh TM, Colgan TJ, Cox J, et al. Anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16:205–42.CrossRefGoogle Scholar
  13. 13.
    Bornstein J, Bogliatto F, Haefner HK, Stockdale CK, Preti M, Bohl TG, Reutter J, ISSVD Terminology Committee. The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology of vulvar squamous intraepithelial lesions. Obstet Gynecol. 2016;127:264–8.CrossRefGoogle Scholar
  14. 14.
    van Seters M, Beckmann I, Heijmans-Antonissen C, van Beurden M, Ewing PC, Zijlstra FJ, Helmerhorst TJ, Klein Jan A. Disturbed patterns of immunocompetent cells in usual-type vulvar intraepithelial neoplasia. Cancer Res. 2008;68:6617–22.CrossRefGoogle Scholar
  15. 15.
    Del Pino M, Rodriguez-Carunchio L, Ordi J. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Histopathology. 2013;62:161–75.CrossRefGoogle Scholar
  16. 16.
    Kokka F, Singh N, Faruqi A, Gibbon K, Rosenthal AN. Is differentiated vulval intraepithelial neoplasia the precursor lesion of human papillomavirus-negative vulval squamous cell carcinoma? Int J Gynecol Cancer. 2011;21:1297–305.CrossRefGoogle Scholar
  17. 17.
    van Seters M, ten Kate FJ, van Beurden M, Verheijen RH, Meijer CJ, Burger MP, Helmerhorst TJ. In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology. J Clin Pathol. 2007;60:504–9.CrossRefGoogle Scholar
  18. 18.
    Davis G, Wentworth J, Richard J. Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases. J Reprod Med. 2000;45:619–23.PubMedGoogle Scholar
  19. 19.
    Van Seters M, van Beurden M, ten Kate FJ, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med. 2008;358:1465.CrossRefGoogle Scholar
  20. 20.
    Mathiesen O, Buus SK, Cramers M. Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomized, double-blinded study. Gynecol Oncol. 2007;107:219–22.CrossRefGoogle Scholar
  21. 21.
    Terlou A, van Seters M, Kleinjan A, Heijmans-Antonissen C, Santegoets LA, Beckmann I, van Beurden M, Helmerhorst TJ, Blok LJ. Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia. Int J Cancer. 2010;127:2831–40.CrossRefGoogle Scholar
  22. 22.
    Westermann C, Fischer A, Clad A. Treatment of vulvar intraepithelial neoplasia with topical 5% imiquimod cream. Int J Gynaecol Obstet. 2013;120:266–70.CrossRefGoogle Scholar
  23. 23.
    Sillman FH, Sedlis A, Boyce JG. A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil. Obstet Gynecol Surv. 1985;40:190.CrossRefGoogle Scholar
  24. 24.
    Krupp PJ, Bohm JW. 5-flurouracil topical treatment of in situ vulvar cancer. A preliminary report. Obstet Gynecol. 1978;51:702.PubMedGoogle Scholar
  25. 25.
    Tristram A, Hurt CN, Madden T, et al. Activity, safety and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicenter, open-label, randomized phase 2 trial. Lancet Oncol. 2014;15:1361–8.CrossRefGoogle Scholar
  26. 26.
    Hillemanns P, Wang X, Staehle S, et al. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO2 laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol. 2006;100:271–5.CrossRefGoogle Scholar
  27. 27.
    Kaufman RH. Intraepithelial neoplasia of the vulva. Gynecol Oncol. 1995;56:8–21.CrossRefGoogle Scholar
  28. 28.
    Modesitt SC, Waters AB, Walton L, et al. Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence. Obstet Gynecol. 1998;92(6):962.PubMedGoogle Scholar
  29. 29.
    Leufflen L, Baermann P Jr, Rauch P, Routiot T, Bezdetnava L, Guillemin F, Desandes E, Marchal F. Treatment of vulvar intraepithelial neoplasia with CO2 laser vaporization and excision surgery. J Low Genit Tract Dis. 2013;17:446–51.CrossRefGoogle Scholar
  30. 30.
    Daayana S, Elkord E, Winters U, Pawlita M, Roden R, Stern PL, Kitchener HC. Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia. Br J Cancer. 2010;102:1129–36.CrossRefGoogle Scholar
  31. 31.
    Liu XS. Non-responders to topical imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10. Br J Cancer. 2010;103:595–6.CrossRefGoogle Scholar
  32. 32.
    Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathological study including analysis of HPV infection and p53 expression. Am J Surg Pathol. 2000;24:429–41.CrossRefGoogle Scholar
  33. 33.
    Van de Nieuwenhof HP, Bulten J, Hollema H, et al. Differentiated VIN is often found in lesions, previously diagnosed as lichen sclerosus, which have progressed to vulvar squamous cell carcinoma. Mod Pathol. 2011;24:297–305.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Fabrizio Bogliatto
    • 1
  1. 1.Department of Obstetrics and GynaecologyLower Female Anourogenital Tract Network, Chivasso Civic HospitalTurinItaly

Personalised recommendations